Literature DB >> 6678698

Natural killer cell activity in inflammatory joint disease.

R D Armstrong, G S Panayi.   

Abstract

The natural killer (NK) cell activity of unfractionated peripheral blood and synovial fluid mononuclear cells from patients with inflammatory joint disease was measured in a short-term assay using the human tumour cell line, K562, as the target. The mean values for peripheral blood NK activity of the various groups (controls, rheumatoid arthritis (RA), ankylosing spondylitis (AS) and psoriatic arthritis (PsA] were similar although the rheumatoid group showed the widest range. However, the NK activity of PsA patients (23.74 +/- 10.14) was significantly lower than that of the controls (31.63 +/- 10.8, 0.05 greater than P greater than 0.01). Almost without exception, NK activity was found to be considerably lower in synovial fluid than in paired blood samples (p less than 0.01).

Entities:  

Mesh:

Year:  1983        PMID: 6678698     DOI: 10.1007/bf02041398

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  37 in total

1.  Augmentation by interferon of human natural and antibody-dependent cell-mediated cytotoxicity.

Authors:  R R Herberman; J R Ortaldo; G D Bonnard
Journal:  Nature       Date:  1979-01-18       Impact factor: 49.962

2.  Natural cytotoxic reactivity of human lymphocytes against a myeloid cell line: characterization of effector cells.

Authors:  W H West; G B Cannon; H D Kay; G D Bonnard; R B Herberman
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

3.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

4.  The cytotoxic activity of mononuclear cells from joint fluid.

Authors:  I C Maclennan; G Loewi
Journal:  Clin Exp Immunol       Date:  1970-05       Impact factor: 4.330

5.  Immunological and functional characteristics of peripheral blood and synovial fluid lymphocytes from patients with rheumatoid arthritis.

Authors:  G R Burmester; J R Kalden; H H Peter; I Schedel; P Beck; A Wittenborg
Journal:  Scand J Immunol       Date:  1978       Impact factor: 3.487

6.  Natural cytotoxicity in rheumatoid arthritis and systemic lupus erythematosus.

Authors:  J Karsh; G Dorval; C K Osterland
Journal:  Clin Immunol Immunopathol       Date:  1981-06

7.  Histocompatibility antigens in psoriasis, psoriatic arthropathy, and ankylosing spondylitis.

Authors:  R D Armstrong; G S Panayi; K I Welsh
Journal:  Ann Rheum Dis       Date:  1983-04       Impact factor: 19.103

8.  Immune interferon in the circulation of patients with autoimmune disease.

Authors:  J J Hooks; H M Moutsopoulos; S A Geis; N I Stahl; J L Decker; A L Notkins
Journal:  N Engl J Med       Date:  1979-07-05       Impact factor: 91.245

9.  Natural killer funciton in systemic lupus erythematosus.

Authors:  T Hoffman
Journal:  Arthritis Rheum       Date:  1980-01

10.  Tumorigenicity and lysis by natural killers.

Authors:  J L Collins; P Q Patek; M Cohn
Journal:  J Exp Med       Date:  1981-01-01       Impact factor: 14.307

View more
  7 in total

Review 1.  Natural killer cells and autoimmunity.

Authors:  E Grunebaum; E Malatzky-Goshen; Y Shoenfeld
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  Activated, cytotoxic lymphocytes in systemic vasculitis.

Authors:  A D Blann; D G Scott
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

3.  Mechanisms of macrophage activation in rheumatoid arthritis: the role of gamma-interferon.

Authors:  M G Ridley; G S Panayi; N S Nicholas; J Murphy
Journal:  Clin Exp Immunol       Date:  1986-03       Impact factor: 4.330

4.  Natural killer cell function in ankylosing spondylitis.

Authors:  D Wendling; E Racadot; M Guidet
Journal:  Ann Rheum Dis       Date:  1988-09       Impact factor: 19.103

5.  Protective role of NK1.1+ cells in experimental Staphylococcus aureus arthritis.

Authors:  N Nilsson; T Bremell; A Tarkowski; H Carlsten
Journal:  Clin Exp Immunol       Date:  1999-07       Impact factor: 4.330

6.  Differential expression of NK receptors CD94 and NKG2A by T cells in rheumatoid arthritis patients in remission compared to active disease.

Authors:  Ceara E Walsh; Elizabeth J Ryan; Cliona O'Farrelly; Lucy Golden-Mason; Oliver FitzGerald; Douglas J Veale; Barry Bresnihan; Ursula Fearon
Journal:  PLoS One       Date:  2011-11-15       Impact factor: 3.240

7.  Killer immunoglobulin-like receptor and human leukocyte antigen-C genotypes in rheumatoid arthritis primary responders and non-responders to anti-TNF-α therapy.

Authors:  Cathy M McGeough; Daniel Berrar; Gary Wright; Clare Mathews; Paula Gilmore; Rodat T Cunningham; Anthony J Bjourson
Journal:  Rheumatol Int       Date:  2011-03-04       Impact factor: 2.631

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.